Kaori Yasuda

Dr. Kaori Yasuda


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KYKaori Yasuda
Kaori Yasuda
MNMiyu Nishikawa
Miyu Nishikawa
KOKairi Okamoto
Kairi Okamoto
KHKyohei Horibe
Kyohei Horibe
HMHiroki Mano
Hiroki Mano
Toshiyuki SakakiToshiyuki Sakaki
Toshiyuki Sakaki
CYP24A1-deficient (Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the prohormone of calcitriol. Plasma 25(OH)D3 concentrations in Cyp24a1 KO rats were approximately two-fold higher than in wild-type rats. Wild-type rats showed five metabolites of 25(OH)D3 in plasma following oral administration of 25(OH)D3, and these metabolites were not detected in Cyp24a1 KO rats. Among these metabolites, 25(OH)D3-26,23-lactone was identified as the second major metabolite with a significantly higher Tmax value than others. When 23S,25(OH)2D3 was administered to Cyp24a1 KO rats, neither 23,25,26(OH)3D3 nor 25(OH)D3-26,23-lactone were observed. However, when 23S,25R,26(OH)3D3 was administered to Cyp24a1 KO rats, plasma 25(OH)D3-26,23-lactone was detected. These results suggested that CYP24A1 is responsible for the conversion of 25(OH)D3 to 23,25,26(OH)3D3 via 23,25(OH)2D3, but enzyme(s) other than CYP24A1 may be involved in the conversion of 23,25,26(OH)3D3 to 25(OH)D3-26,23-lactone. Enzymatic studies using recombinant human CYP species and the inhibitory effects of ketoconazole suggested that CYP3A plays an essential role in the conversion of 23,25,26(OH)3D3 into 25(OH)D3-26,23-lactone in both rats and humans. Taken together, our data indicate that Cyp24a1 KO rats are valuable for metabolic studies of vitamin D and its analogs. In addition, long-term administration of 25(OH)D3 to Cyp24a1 KO rats at 110 μg/kg body weight/day resulted in significant weight loss and ectopic calcification. Thus, Cyp24a1 KO rats could represent an important model for studying renal diseases originating from CYP24A1 dysfunction.

1 January 2013 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
KYKaori Yasuda
Kaori Yasuda
SIShinichi Ikushiro
Shinichi Ikushiro
MKMasaki Kamakura
Masaki Kamakura
MTMasashi Takano
Masashi Takano
NSNozomi Saito
Nozomi Saito
Toshiyuki SakakiToshiyuki Sakaki
Toshiyuki Sakaki

15 January 2024 in Gels
Verified
Journal Article
Open access
PDF file
RYRio Yamagishi
Rio Yamagishi
SMSayaka Miura
Sayaka Miura
KYKana Yabu
Kana Yabu
MAMano Ando
Mano Ando
YHYuna Hachikubo
Yuna Hachikubo
Satoshi TakeiSatoshi Takei
Satoshi Takei
Microneedles are of great interest in diverse fields, including cosmetics, drug delivery systems, chromatography, and biological sensing for disease diagnosis. Self-dissolving ultrafine microneedles of pure sodium hyaluronate hydrogels were fabricated using a UV-curing TiO2-SiO2 gas-permeable mold polymerized by sol-gel hydrolysis reactions in nanoimprint lithography processes under refrigeration at 5 °C, where thermal decomposition of microneedle components can be avoided. The moldability, strength, and dissolution behavior of sodium hyaluronate hydrogels with different molecular weights were compared to evaluate the suitability of ultrafine microneedles with a bottom diameter of 40 μm and a height of 80 μm. The appropriate molecular weight range and formulation of pure sodium hyaluronate hydrogels were found to control the dissolution behavior of self-dissolving ultrafine microneedles while maintaining the moldability and strength of the microneedles. This fabrication technology of ultrafine microneedles expands their possibilities as a next-generation technique for bioactive gels for controlling the blood levels of drugs and avoiding pain during administration.

1 November 2016 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
NBNarasimha Rao Bolla
Narasimha Rao Bolla
ACAoife Corcoran
Aoife Corcoran
KYKaori Yasuda
Kaori Yasuda
MCMichał Chodyński
Michał Chodyński
KKKrzysztof Krajewski
Krzysztof Krajewski
Andrzej KutnerAndrzej Kutner
Andrzej Kutner

Verified
Journal Article
Open access
PDF file
FKFumihiro Kawagoe
Fumihiro Kawagoe
SMSayuri Mototani
Sayuri Mototani
KYKaori Yasuda
Kaori Yasuda
HMHiroki Mano
Hiroki Mano
Toshiyuki SakakiToshiyuki Sakaki
Toshiyuki Sakaki
AKAtsushi Kittaka
Atsushi Kittaka
Two 24-fluoro-25-hydroxyvitamin D3 analogues (3,4) were synthesized in a convergent manner. The introduction of a stereocenter to the vitamin D3 side-chain C24 position was achieved via Sharpless dihydroxylation, and a deoxyfluorination reaction was utilized for the fluorination step. Comparison between (24R)- and (24S)-24-fluoro-25-hydroxyvitamin D3 revealed that the C24-R-configuration isomer 4 was more resistant to CYP24A1-dependent metabolism than its 24S-isomer 3. The new synthetic route of the CYP24A1 main metabolite (24R)-24,25-dihydroxyvitamin D3 (6) and its 24S-isomer (5) was also studied using synthetic intermediates (30,31) in parallel.

18 September 2015 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
HMHiroki Mano
Hiroki Mano
MNMiyu Nishikawa
Miyu Nishikawa
KYKaori Yasuda
Kaori Yasuda
SIShinichi Ikushiro
Shinichi Ikushiro
NSNozomi Saito
Nozomi Saito
Toshiyuki SakakiToshiyuki Sakaki
Toshiyuki Sakaki